WinstonWınston
Waters Corporation logo

Waters Corporation

WAT
34
Medical - Diagnostics & Research · Healthcare
Price
$368.98
-9.21 (-2.44%)
Market Cap
$24.05B
Winston Score
34
Winston is serious
Below-average fundamentals — multiple weak pillars.

Share count falling — buybacks

3.7% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 62.0M (2021) → 59.7M (2025)

Waters Corporation makes scientific instruments that help researchers and companies analyze the chemical makeup of substances. Their main products are liquid chromatography systems and mass spectrometers, which are machines used to separate and identify molecules. Pharmaceutical companies are their biggest customers, but they also sell to food safety labs, environmental testing facilities, and government research agencies.

Waters earns most of its revenue by selling hardware instruments, along with recurring income from consumable supplies, software, and service contracts that keep those machines running. The company operates globally, with significant sales in the United States, Europe, and Asia, and generates roughly $3 billion in annual revenue. Its moat comes from the high switching costs of its specialized instruments and the long-term service relationships it builds with customers. The key growth driver is demand from pharmaceutical and biotech companies developing new drugs, though a slowdown in pharmaceutical spending or increased competition from rivals like Agilent and Thermo Fisher could pressure future results.

Winston Score History

Politician Trades

26 trades / 12mo

17 Congressional buys and 7 sells on WAT in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+91.5% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

-142.6% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$195M/ year

Rising (+7% vs prior year)

6.2% of revenue

Below sector average (18%)

R&D investment increasing — building for the future

Insider Activity

0.1%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~3 years

$462M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

$462M cash & investments at current burn rate

Revenue accelerating

Waters Corporation grew revenue 91% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
47.0%
Healthy — 47.0% gross margin
Operating Margin
-3.7%
Losing money on operations — -3.7%
ROCE
-0.2%
Weak — -0.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+26.4%
Fast-growing sales (26.4% YoY)
EPS YoY
-28.8%
Earnings shrinking (-28.8% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
87%
Modest — 87% of profit becomes cash
FCF Margin
7.0%
Modest free cash flow (7.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.34
Conservative — low debt load (0.34)
Interest Cover
7.03x
Adequate interest coverage (7.0x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
46.8x
Expensive — P/E 46.8

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+26.4
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (46.8 → 20.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial